Successful treatment of refractory systemic lupus erythematosus-associated immune thrombocytopenia with drug-induced liver injury with telitacicept: a case report and review
Immune thrombocytopenia(ITP)is a common clinical manifestation of systemic lupus erythematosus(SLE). Drug therapy includes glucocorticoids(GCs),disease-modifying anti-rheumatic drugs (DMARDs) and biologics. Refractory thrombocytopenia can be life-threatening, and the use of effective medications pla...
Saved in:
| Main Authors: | Xuefei Li, Yao Fu, HaiQin Yin, Huiling Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1473190/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prospective analysis of B cell subset dynamics following telitacicept treatment in systemic lupus erythematosus
by: Xiaowei Chen, et al.
Published: (2025-06-01) -
Comparative efficacy and safety of different recommended doses of telitacicept in patients with systemic lupus erythematosus in China: a systematic review and meta-analysis
by: Shenglan Gao, et al.
Published: (2025-01-01) -
BAFF/APRIL expression-guided telitacicept therapy demonstrates superior efficacy in systemic lupus erythematosus patients: a real-world comparative study
by: Li Huang, et al.
Published: (2025-08-01) -
Efficacy and safety of telitacicept in systemic lupus erythematosus with lupus nephritis and nephrotic syndrome: a 12-month retrospective cohort study
by: Min-Ying Liu, et al.
Published: (2025-07-01) -
Pregnancy outcomes and risk factors for thrombocytopenia in pregnant patients with systemic lupus erythematosus
by: Qing-Ying Fang, et al.
Published: (2025-03-01)